Coordinating Center for Cannabis and Cannabinoid Use in Adult Cancer Patients During Treatment: Assessing Benefits and Harms (U24 Clinical Trial Not Allowed)

US Dept. of Health & Human Services: National Institutes of Health (NIH)

View website    Save this grant

Deadline: Feb 17, 2023 (Full proposal)

Grant amount: Up to US $500,000

Fields of work: Cancer/Oncology Drug Safety

Applicant type: Government Entity, Nonprofit, For-Profit Business, Indigenous Group

Funding uses: Research, Training / Capacity Building

Location of project: United States

Location of residency: United States


Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) and National Institute on Drug Abuse (NIDA) will support a coordinating center to facilitate coordination of research activities between the new Cooperative Agreements U01 awards supported under the companion RFA-CA-22-052. The coordinating center will have several responsibilities, including, but not limited to provide logistical and administrative support to the U01 awards supported under the companion RFA-CA-22-052. Their responsibilities will involve working with the U01 awardees to facilitate sharing of data collection instruments, measures and resources, and identify a core set of questions to be included in data collection across the funded studies. They will also create standard operating procedures and ensure best practices are followed for data and biospecimen collection and analytical assays. In addition, they will facilitate communication across cohorts, coordinate topical working groups around key scientific issues that cut across individual U01 projects, provide meeting support, create and maintain a project website, and facilitate deposition of data to NIH repositories.

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.

Other Opportunities from Us Dept. Of Health & Human Services: National Institutes Of Health (Nih)

This page was last reviewed October 04, 2022 and last updated October 04, 2022